We are live on
!
Find out more
PA
Profund Advisors Portfolio holdings
AUM
$2.72B
1-Year Est. Return
47.27%
This Fund
S&P 500
This Quarter
Est. Return
+2.46%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$1.42B
AUM Growth
–
Cap. Flow
+$1.43B
Cap. Flow
% of AUM
101.06%
Top 10 Holdings %
Top 10 Hldgs %
18.66%
Holding
1,386
New
1,386
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$41.1M |
| 2 |
Amgen
AMGN
|
+$40.3M |
| 3 |
AbbVie
ABBV
|
+$32.9M |
| 4 |
ExxonMobil
XOM
|
+$26.5M |
| 5 |
Biogen
BIIB
|
+$26.2M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.46% |
| 2 | Technology | 11.46% |
| 3 | Financials | 10.21% |
| 4 | Energy | 9.8% |
| 5 | Consumer Discretionary | 7.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Duke Energy
DUK
$101B
| $4.09M | 0.29% |
+60,570
| New | +$4.28M |
|
52
Philip Morris
PM
$298B
| $4.02M | 0.28% |
+46,429
| New | +$4.31M |
|
53
Costco
COST
$411B
| $3.83M | 0.27% |
+34,626
| New | +$3.79M |
|
54
Abbott
ABT
$175B
| $3.81M | 0.27% |
+109,230
| New | +$4.01M |
|
55
UnitedHealth
UNH
$385B
| $3.8M | 0.27% |
+58,006
| New | +$3.61M |
|
56
Starbucks
SBUX
$118B
| $3.78M | 0.27% |
+115,504
| New | +$3.59M |
|
57
Mondelez International
MDLZ
$77.1B
| $3.78M | 0.27% |
+132,380
| New | +$4.03M |
|
|
CHL
58
DELISTED
China Mobile Limited
CHL
| $3.75M | 0.27% |
+72,509
| New | +$3.83M |
|
59
PepsiCo
PEP
$184B
| $3.58M | 0.25% |
+43,837
| New | +$3.58M |
|
|
DD
60
DELISTED
Du Pont De Nemours E I
DD
| $3.58M | 0.25% |
+71,866
| New | +$3.63M |
|
61
BioMarin Pharmaceuticals
BMRN
$11.4B
| $3.54M | 0.25% |
+63,505
| New | +$3.96M |
|
62
Halliburton
HAL
$27.3B
| $3.36M | 0.24% |
+80,636
| New | +$3.37M |
|
63
Baidu
BIDU
$36.5B
| $3.36M | 0.24% |
+35,530
| New | +$3.27M |
|
64
US Bancorp
USB
$98.7B
| $3.36M | 0.24% |
+92,917
| New | +$3.19M |
|
65
Eli Lilly
LLY
$1.06T
| $3.35M | 0.24% |
+68,250
| New | +$3.71M |
|
|
MON
66
DELISTED
Monsanto Co
MON
| $3.34M | 0.24% |
+33,765
| New | +$3.54M |
|
67
Southern Company
SO
$109B
| $3.31M | 0.23% |
+74,922
| New | +$3.45M |
|
68
RTX Corp
RTX
$282B
| $3.02M | 0.21% |
+51,704
| New | +$3.06M |
|
|
PTR
69
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $3.01M | 0.21% |
+27,198
| New | +$3.28M |
|
70
Crown Castle
CCI
$32.5B
| $2.99M | 0.21% |
+41,330
| New | +$3.03M |
|
|
FON
71
DELISTED
SPRINT CORP FON COM
FON
| $2.98M | 0.21% |
+424,630
| New | +$2.98M |
|
72
Newmont
NEM
$101B
| $2.97M | 0.21% |
+99,088
| New | +$3.33M |
|
73
Meta Platforms (Facebook)
META
$1.54T
| $2.95M | 0.21% |
+118,792
| New | +$3.04M |
|
74
Texas Instruments
TXN
$259B
| $2.93M | 0.21% |
+84,110
| New | +$3.01M |
|
|
ONXX
75
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
| $2.9M | 0.21% |
+33,428
| New | +$3.08M |
|
Similar funds
MASUI
XL
MSL
CA
APSPRSPT
TAM
NCM
GC
Profund Advisors's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Profund Advisors, which disclosed 1,386 positions worth $1.42B. Its ten largest holdings account for 19% of the portfolio.
Its largest position is Gilead Sciences: 789,103 shares worth $40.4M.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, followed by Technology and Financials.
- Profund Advisors's largest Q2 2013 buy was Gilead Sciences: 789,103 shares worth $40.4M.
- Profund Advisors's ten largest holdings make up 19% of its $1.42B portfolio in Q2 2013.
- Profund Advisors disclosed 1,386 positions in Q2 2013, its first 13F filing on record.
Based on Profund Advisors's 13F filing for Q2 2013, filed 25 Jul 2013.